BIOMAT Database Logo BIOMAT Database Logo

Adrenal suppression among asthmatic children receiving chronic therapy with inhaled corticosteroid with and without spacer device. 1996

S Goldberg, and N Algur, and M Levi, and E Brukheimer, and H J Hirsch, and D Branski, and E Kerem
Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel.

BACKGROUND Inhaled corticosteroids have become a first-line treatment for chronic asthma. It has been shown that inhaled corticosteroids can have a measurable effect on the hypothalamic-pituitary-adrenal axis in asthmatic children. OBJECTIVE To investigate the prevalence of adrenal suppression among asthmatic children receiving chronic therapy with low to moderate doses (up to 1000 micrograms) of inhaled beclomethasone dipropionate via a metered dose inhaler (MDI) and via MDI attached to a spacer device (MDI-spacer). METHODS The study included 39 asthmatic children currently undergoing therapy; 24 received beclomethasone dipropionate by MDI attached to a spacer, and 15 directly by MDI. All the patients had been treated for at least 4 months. Another 21 children were normal controls. The 24-hour urinary free cortisol excretion was measured to evaluate hypothalamic-pituitary-adrenal axis function. RESULTS Seven of 15 (47%) patients from the MDI group had reduced 24 hour-urinary free cortisol excretion and 2 of 24 (8%) in the MDI-spacer group (P = .006). The mean 24-hour urinary free cortisol excretion of the MDI group was 0.0185 +/- 0.0089 microgram/gram creatinine, and the MDI-spacer and the control groups were, 0.0290 +/- 0.0138 microgram/gram creatinine and 0.0270 +/- 0.0118 microgram/gram creatinine, respectively, (P = 0.37, f = 3.51 ANOVA). CONCLUSIONS Chronic inhalation of low to moderate doses of corticosteroids is associated with adrenal suppression in some asthmatic children. This side effect is more common among patients inhaling directly from the MDI and is less frequent when a large volume spacer is attached to the MDI.

UI MeSH Term Description Entries
D008297 Male Males
D009330 Nebulizers and Vaporizers Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments. Atomizers,Inhalation Devices,Inhalators,Inhalers,Vaporizers,Nebulizers,Vaporizers and Nebulizers,Atomizer,Device, Inhalation,Devices, Inhalation,Inhalation Device,Inhalator,Inhaler,Nebulizer,Vaporizer
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000305 Adrenal Cortex Hormones HORMONES produced by the ADRENAL CORTEX, including both steroid and peptide hormones. The major hormones produced are HYDROCORTISONE and ALDOSTERONE. Adrenal Cortex Hormone,Corticoid,Corticoids,Corticosteroid,Corticosteroids,Cortex Hormone, Adrenal,Hormone, Adrenal Cortex,Hormones, Adrenal Cortex

Related Publications

S Goldberg, and N Algur, and M Levi, and E Brukheimer, and H J Hirsch, and D Branski, and E Kerem
Adrenal suppression with cushingoid features from inhaled corticosteroid therapy in an adult asthmatic patient.
May 2014, The American journal of medicine,
S Goldberg, and N Algur, and M Levi, and E Brukheimer, and H J Hirsch, and D Branski, and E Kerem
Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
September 1996, Thorax,
S Goldberg, and N Algur, and M Levi, and E Brukheimer, and H J Hirsch, and D Branski, and E Kerem
[Inhaled corticosteroid therapy and bone metabolism in asthmatic children].
May 2007, Anales de pediatria (Barcelona, Spain : 2003),
S Goldberg, and N Algur, and M Levi, and E Brukheimer, and H J Hirsch, and D Branski, and E Kerem
Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate.
April 1986, Lancet (London, England),
S Goldberg, and N Algur, and M Levi, and E Brukheimer, and H J Hirsch, and D Branski, and E Kerem
[Bronchodilating effect of terbutaline inhaled with and without a tube spacer in asthmatic children].
June 1987, Anales espanoles de pediatria,
S Goldberg, and N Algur, and M Levi, and E Brukheimer, and H J Hirsch, and D Branski, and E Kerem
Varicella in asthmatic children receiving alternate-day corticosteroid therapy.
February 1973, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
S Goldberg, and N Algur, and M Levi, and E Brukheimer, and H J Hirsch, and D Branski, and E Kerem
Inhaled corticosteroid therapy is safe in tuberculin-positive asthmatic children.
March 2000, The Pediatric infectious disease journal,
S Goldberg, and N Algur, and M Levi, and E Brukheimer, and H J Hirsch, and D Branski, and E Kerem
Inhaled corticosteroid use in asthmatic children receiving Ohio Medicaid: trend analysis, 1997-2001.
June 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
S Goldberg, and N Algur, and M Levi, and E Brukheimer, and H J Hirsch, and D Branski, and E Kerem
Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 1. General principles.
January 1998, Neuroimmunomodulation,
S Goldberg, and N Algur, and M Levi, and E Brukheimer, and H J Hirsch, and D Branski, and E Kerem
Optimizing inhaled corticosteroid therapy in children with chronic asthma.
January 2005, Pediatric pulmonology,
Copied contents to your clipboard!